Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading Conference

Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading Conference GlobeNewswire June 02, 2025 NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global financial services platform, announces that it will be participating in a fireside chat at Piper Sandler's Global Exchange & Trading […]

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

Immunocore to present at the 2025 Jefferies Global Healthcare Conference GlobeNewswire June 02, 2025 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, June 2, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases

Vanguard Food LP Announces Closing of Transaction to Create Emerging Leader in North American Produce Industry

Vanguard Food LP Announces Closing of Transaction to Create Emerging Leader in North American Produce Industry GlobeNewswire June 02, 2025 – Transaction creates new joint-venture in the North American produce industry backed by private investment firms – – Parties intend to provide additional capital to execute a roll-up strategy of other produce assets and operations

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress Company to host conference call and webcast on June 9, 2025, at 8:00 a.m. ET GlobeNewswire June 02, 2025 SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology

CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025

CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025 GlobeNewswire June 02, 2025 Katy, Texas, June 02, 2025 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors the Company remains on track to produce annual revenues between

Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis

Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis GlobeNewswire June 02, 2025 – Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time, and Affinity to Thymic Stromal Lymphopoietin (TSLP) – – Top Line Results Expected in the Second Half of 2026 – WAYNE, Pa., June 02,

West Fraser Credit Facility and Term Loan Renewals Increase Liquidity

Today, West Fraser Timber Co. Ltd. (“West Fraser” or the “Company”) (TSX and NYSE: WFG) announced it has entered into a syndicated credit agreement providing for the renewal of its $1 billion credit facility and extension of the facility's maturity from July 2028 to May 2030. The renewed credit facility is undrawn and is made

SAIC Announces First Quarter of Fiscal Year 2026 Results

(NASDAQ:SAIC), Revenues of $1.88 billion; approximately 2% revenue growth Net bookings of $2.4 billion; book-to-bill ratio of 1.3 Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1) of $1.92 Cash flows provided by operating activities of $100 million; Free

SAIC Announces First Quarter of Fiscal Year 2026 Results

SAIC Announces First Quarter of Fiscal Year 2026 Results GlobeNewswire June 02, 2025 Revenues of $1.88 billion; approximately 2% revenue growth Net bookings of $2.4 billion; book-to-bill ratio of 1.3 Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1)

Cancer mRNA Vaccine Clinical Trials FDA Approval mRNA Therapies Clinical Advances Insight

Cancer mRNA Vaccine Clinical Trials FDA Approval mRNA Therapies Clinical Advances Insight Cancer mRNA Vaccine Commercial Availability Expected By 2029 Says Kuick Research In New Study GlobeNewswire June 02, 2025 Delhi, June 02, 2025 (GLOBE NEWSWIRE) — mRNA cancer vaccines approach clinical maturity, the commercial landscape surrounding them is rapidly changing. Over 60 candidates in

Scroll to Top